Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Sandra who wrote (491)	12/30/1997 6:22:00 PM
From: tony di fatta	Read Replies (1) \| Respond to of 1837

hi, before we all get too excited , is this drug much bigger then the approval several months ago. then it went up for a day and then did nothing for a long time. anyone has an idea on market size? thanks tony

To: Sandra who wrote (491)	12/30/1997 6:36:00 PM
From: tommysdad	Read Replies (1) \| Respond to of 1837

Sorry, the market for estradiol is NOT huge. From the company's own press release, the market is maybe $100M, and Duramed is not going to capture a significant market share right off the bat. You're confusing estradiol with conjugated estrogens -- the market for which IS large. And rather than an equivalency, Duramed is apparently going after an NDA -- a little tougher to get approved.